Atara CTO Charlene Banard departs; signs consulting deal through Sept 2023

Atara Biotherapeutics, Inc.

Charlene Banard, EVP and Chief Technical Officer, left Atara on June 9, 2023.
She entered a consulting agreement with Atara from June 9 through September 30, 2023.
Consulting fee: $2,000 monthly for up to specified hours, plus $220/hr for excess hours.
Her outstanding equity awards will continue to vest during the consulting term.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Charlene Banard

Executive Vice President, Chief Technical Officer

ATRA · Atara Biotherapeutics, Inc.

Effective: 2023-06-09
Filed: June 9, 2023, 7:59 PM ET

On May 8, 2023, Atara Biotherapeutics, Inc., a Delaware corporation (the “Company”), announced that Charlene Banard, the Company’s Executive Vice President, Chief Technical Officer, would depart the Company on June 9, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Charlene Banard departed as Executive Vice President, Chief Technical Officer at Atara Biotherapeutics, Inc..

Action: departed
Role: Executive Vice President, Chief Technical Officer

Exact text from the filing

On May 8, 2023, Atara Biotherapeutics, Inc., a Delaware corporation (the “Company”), announced that Charlene Banard, the Company’s Executive Vice President, Chief Technical Officer, would depart the Company on June 9, 2023.

View on SEC.gov

Atara Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-027257

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.